After three years of rigorous negotiations, the Multidisciplinary Association for Psychedelic Studies (MAPS) has achieved a significant breakthrough. The FDA has cleared their Phase 2 study investigating smoked cannabis as a treatment for PTSD in veterans, marking a pivotal moment in cannabis research history. The Journey to FDA Clearance The path to approval involved complex […]